Skip to content Inauguração emGrand opening inInauguración en --d --h --m --s · Cadastro VIP ›· VIP sign-up ›· Registro VIP › Abrimos hoje · aguardeWe open today · hold onAbrimos hoy · aguarde Loja aberta! Entrar ›Store open! Enter ›¡Tienda abierta! Entrar ›

KNOWLEDGE · COMPOUNDS

Kisspeptin-10

ImmunityClinical trialsPubMed records: 200count from PubMed, not curated

Evidence gap. O site diferencia kisspeptin-10 de kisspeptin-54, declara que nenhum produto de kisspeptina é aprovado pela FDA e apresenta as faixas como planejamento de pesquisa, não como protocolo aprovado. Search performed →

Overview

O Kisspeptin-10 é um fragmento de 10 aminoácidos do hormônio kisspeptina, regulador central da puberdade e reprodução. Atua diretamente nos neurônios GnRH do hipotálamo, estimulando liberação pulsátil de LH e FSH. Pesquisado como alternativa ao HCG em protocolos de fertilidade. Original in PT-BR

Kisspeptin-10 is catalogued under Immunity. 17 Eagle articles in this library reference this compound.

Category
Immunity
Research stage
Clinical trials — Ensaios Clínicos (fertilidade e endocrinologia) Original in PT-BR
PubMed records
200 (count from PubMed, not curated)
Eagle articles on this compound
17 Eagle articles

Mechanism

Estimula eixo GnRH → LH/FSH — regulador central da função reprodutiva Original in PT-BR

O Kisspeptin é um neuropeptídeo produzido no hipotálamo que atua como regulador mestre do eixo reprodutivo. Liga-se ao receptor KISS1R (GPR54) nos neurônios GnRH, estimulando a liberação pulsátil de GnRH, que por sua vez estimula LH e FSH na hipófise anterior. O Kisspeptin-10 (fragmento C-terminal ativo) é suficiente para ativar o receptor. Em ensaios clínicos, demonstrou estimulação de LH comparável ao GnRH exógeno, com potencial como gatilho de ovulação em FIV (menor risco de hiperestimulação ovariana vs HCG). Em homens, estimula testosterona endógena via aumento de LH. Original in PT-BR

Eagle articles on this compound

Chemical information

CAS
374675-21-5
Molecular formula
C₆₃H₈₃N₁₇O₁₄
Molecular weight
1302.43 g/mol
Sequence
YNWNSFGLRF
Amino acids
10 counted from the sequence above
Solubility
Água bacteriostática, soro fisiológico Original in PT-BR
Stability
Liofilizado: estável a -20°C. Reconstituído: 7-14 dias a 2-8°C Original in PT-BR
Half-life
~4-5 minutos (IV), ~30 min (SC) Original in PT-BR
Bioavailability
Alta (SC/IV) Original in PT-BR
Onset
Minutos (pico de LH em 30-60 min) Original in PT-BR
Routes
IV · SC

Research references

No individual dosing recommendation is given. Values are as recorded in the source, with species and route stated where known.

Evidence gap. O site diferencia kisspeptin-10 de kisspeptin-54, declara que nenhum produto de kisspeptina é aprovado pela FDA e apresenta as faixas como planejamento de pesquisa, não como protocolo aprovado.

Search performed — kisspeptin-10 protocolo humano aprovado · Peptide Dosing Protocols · returned: 1 · relevant: 0 · checked 2026-09

Broad control search — site:peptidedosingprotocols.com/protocol/kisspeptin kisspeptin · Peptide Dosing Protocols · returned: 1 · checked 2026-09. A busca de controle confirmou a página do protocolo; a própria página separa pesquisa comunitária de aprovação clínica.

Third-party research score

70/ 100

Score assigned by the imported source, on its own scale and with no published methodology. Eagle does not compute it, does not verify it and does not endorse it. It appears here to preserve the record, not as an assessment.

  • Primeira demonstração de que kisspeptin estimula LH/FSH em humanos de forma dose-dependente Original in PT-BR

    PMID: 15919950Year: 2005Species: Not recorded as a structured field in the source.Route: Not recorded as a structured field in the source.Duration: Not recorded as a structured field in the source.Purpose: Not recorded as a structured field in the source.
  • Kisspeptin como gatilho de ovulação — menor risco de OHSS vs HCG Original in PT-BR

    PMID: 20032151Year: 2010Species: Not recorded as a structured field in the source.Route: Not recorded as a structured field in the source.Duration: Not recorded as a structured field in the source.Purpose: Not recorded as a structured field in the source.
  • Kisspeptin aumenta testosterona em homens via estimulação de LH Original in PT-BR

    PMID: 28899671Year: 2017Species: Not recorded as a structured field in the source.Route: Not recorded as a structured field in the source.Duration: Not recorded as a structured field in the source.Purpose: Not recorded as a structured field in the source.

Safety

Commonly reported

  • Sensação de calor facial
  • Rubor transitório
  • Leve desconforto abdominal

Serious

  • Sem efeitos adversos graves reportados em ensaios clínicos

Contraindications

  • Tumores hormônio-dependentes
  • Gravidez (exceto uso obstétrico supervisionado)
  • Puberdade precoce

Warnings

  • Meia-vida muito curta — ação transitória
  • Dosagem de pesquisa — não para uso clínico não supervisionado
  • Pode causar dessensibilização do eixo com doses altas crônicas

Original in PT-BR — This text was written in Brazilian Portuguese and is shown as recorded. Open the PT-BR page for Kisspeptin-10.

Lab tests named in the source

  • LH
  • FSH
  • Testosterona total/livre
  • Estradiol
  • Progesterona (mulheres)

The source names the tests and nothing else: no reference values and no thresholds. None were added here. Interpreting a result is a clinical act and is not offered on this page.

Reported protocols

Recorded in the imported source as community protocols. They are NOT Eagle protocols, were not reviewed by Eagle, and are not a dosing recommendation, a prescription or clinical guidance. Values appear exactly as recorded, in the language they were written in.

Dosing summary as recorded

Dose (pesquisa)
1-10 nmol/kg IV ou SC Original in PT-BR
Via
SC ou IV Original in PT-BR
Frequência
Variável (protocolo de pesquisa) Original in PT-BR
Status
Pesquisa clínica — sem protocolo aprovado Original in PT-BR

Vial sizes: 5mg — Peptide Calculator

Interactions

These relations come from the imported reference material, which records one label and one comment per pair and no source: no PMID, no population or model, no evidence type and no degree of certainty. Eagle did not verify them and does not endorse them. «Compatible», «Caution» and «Avoid» are the imported material's wording, not an Eagle authorisation or prohibition, and none of this is medical advice.

Compatible

Caution

Related

View all (17)

← Back to knowledge area